131 related articles for article (PubMed ID: 38646857)
1. Worldwide Increasing Use of Nonfasting Rather Than Fasting Lipid Profiles.
Langsted A; Nordestgaard BG
Clin Chem; 2024 Apr; ():. PubMed ID: 38646857
[TBL] [Abstract][Full Text] [Related]
2. Nonfasting versus fasting lipid profile for cardiovascular risk prediction.
Langsted A; Nordestgaard BG
Pathology; 2019 Feb; 51(2):131-141. PubMed ID: 30522787
[TBL] [Abstract][Full Text] [Related]
3. A Test in Context: Lipid Profile, Fasting Versus Nonfasting.
Nordestgaard BG
J Am Coll Cardiol; 2017 Sep; 70(13):1637-1646. PubMed ID: 28935041
[TBL] [Abstract][Full Text] [Related]
4. Fasting and nonfasting lipid levels: influence of normal food intake on lipids, lipoproteins, apolipoproteins, and cardiovascular risk prediction.
Langsted A; Freiberg JJ; Nordestgaard BG
Circulation; 2008 Nov; 118(20):2047-56. PubMed ID: 18955664
[TBL] [Abstract][Full Text] [Related]
5. Nonfasting hyperlipidemia and cardiovascular disease.
Nordestgaard BG; Langsted A; Freiberg JJ
Curr Drug Targets; 2009 Apr; 10(4):328-35. PubMed ID: 19355857
[TBL] [Abstract][Full Text] [Related]
6. Fasting compared with nonfasting lipids and apolipoproteins for predicting incident cardiovascular events.
Mora S; Rifai N; Buring JE; Ridker PM
Circulation; 2008 Sep; 118(10):993-1001. PubMed ID: 18711012
[TBL] [Abstract][Full Text] [Related]
7. Comparison of nonfasting and fasting lipoprotein subfractions and size in 15,397 apparently healthy individuals: An analysis from the VITamin D and OmegA-3 TriaL.
Farukhi ZM; Demler OV; Caulfield MP; Kulkarni K; Wohlgemuth J; Cobble M; Luttmann-Gibson H; Li C; Nelson JR; Cook NR; Buring JE; Krauss RM; Manson JE; Mora S
J Clin Lipidol; 2020; 14(2):241-251. PubMed ID: 32205068
[TBL] [Abstract][Full Text] [Related]
8. Association of Nonfasting vs Fasting Lipid Levels With Risk of Major Coronary Events in the Anglo-Scandinavian Cardiac Outcomes Trial-Lipid Lowering Arm.
Mora S; Chang CL; Moorthy MV; Sever PS
JAMA Intern Med; 2019 Jul; 179(7):898-905. PubMed ID: 31135812
[TBL] [Abstract][Full Text] [Related]
9. The relationship between nonfasting and fasting lipid measurements in patients with or without type 2 diabetes mellitus receiving treatment with 3-hydroxy-3-methylglutaryl-coenzyme A reductase inhibitors.
Weiss R; Harder M; Rowe J
Clin Ther; 2003 May; 25(5):1490-7. PubMed ID: 12867223
[TBL] [Abstract][Full Text] [Related]
10. Proportion of adults fasting for lipid testing relative to guideline changes in Alberta.
Ma I; Viczko J; Naugler C
Clin Biochem; 2017 Apr; 50(6):344-346. PubMed ID: 27919599
[TBL] [Abstract][Full Text] [Related]
11. Postprandial Dyslipidemia: Pathophysiology and Cardiovascular Disease Risk Assessment.
Higgins V; Adeli K
EJIFCC; 2017 Oct; 28(3):168-184. PubMed ID: 29075168
[TBL] [Abstract][Full Text] [Related]
12. A comparison of lipid and lipoprotein measurements in the fasting and nonfasting states in patients with type 2 diabetes.
Dungan KM; Guster T; DeWalt DA; Buse JB
Curr Med Res Opin; 2007 Nov; 23(11):2689-95. PubMed ID: 17892636
[TBL] [Abstract][Full Text] [Related]
13. Fasting Is Not Routinely Required for Determination of a Lipid Profile: Clinical and Laboratory Implications Including Flagging at Desirable Concentration Cutpoints-A Joint Consensus Statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine.
Nordestgaard BG; Langsted A; Mora S; Kolovou G; Baum H; Bruckert E; Watts GF; Sypniewska G; Wiklund O; Borén J; Chapman MJ; Cobbaert C; Descamps OS; von Eckardstein A; Kamstrup PR; Pulkki K; Kronenberg F; Remaley AT; Rifai N; Ros E; Langlois M;
Clin Chem; 2016 Jul; 62(7):930-46. PubMed ID: 27235445
[TBL] [Abstract][Full Text] [Related]
14. Fasting is not routinely required for determination of a lipid profile: clinical and laboratory implications including flagging at desirable concentration cut-points-a joint consensus statement from the European Atherosclerosis Society and European Federation of Clinical Chemistry and Laboratory Medicine.
Nordestgaard BG; Langsted A; Mora S; Kolovou G; Baum H; Bruckert E; Watts GF; Sypniewska G; Wiklund O; Borén J; Chapman MJ; Cobbaert C; Descamps OS; von Eckardstein A; Kamstrup PR; Pulkki K; Kronenberg F; Remaley AT; Rifai N; Ros E; Langlois M;
Eur Heart J; 2016 Jul; 37(25):1944-58. PubMed ID: 27122601
[TBL] [Abstract][Full Text] [Related]
15. Assessing the dyslipidemias: to fast or not to fast?
Farukhi Z; Mora S
Curr Opin Endocrinol Diabetes Obes; 2021 Apr; 28(2):97-103. PubMed ID: 33481424
[TBL] [Abstract][Full Text] [Related]
16. Nonfasting non-high-density lipoprotein cholesterol is adequate for lipid management in hemodialysis patients.
Desmeules S; Arcand-Bossé JF; Bergeron J; Douville P; Agharazii M
Am J Kidney Dis; 2005 Jun; 45(6):1067-72. PubMed ID: 15957136
[TBL] [Abstract][Full Text] [Related]
17. Fasting Versus Nonfasting and Low-Density Lipoprotein Cholesterol Accuracy.
Sathiyakumar V; Park J; Golozar A; Lazo M; Quispe R; Guallar E; Blumenthal RS; Jones SR; Martin SS
Circulation; 2018 Jan; 137(1):10-19. PubMed ID: 29038168
[TBL] [Abstract][Full Text] [Related]
18. Nonfasting Lipid Profile May Suffice to Manage Dyslipidemia.
Andrade C
Indian J Psychol Med; 2020; 42(3):316-317. PubMed ID: 32612341
[TBL] [Abstract][Full Text] [Related]
19. Prognostic value of fasting versus nonfasting low-density lipoprotein cholesterol levels on long-term mortality: insight from the National Health and Nutrition Examination Survey III (NHANES-III).
Doran B; Guo Y; Xu J; Weintraub H; Mora S; Maron DJ; Bangalore S
Circulation; 2014 Aug; 130(7):546-53. PubMed ID: 25015340
[TBL] [Abstract][Full Text] [Related]
20. Association of fasting and nonfasting serum triglycerides with cardiovascular disease and the role of remnant-like lipoproteins and small dense LDL.
Stalenhoef AF; de Graaf J
Curr Opin Lipidol; 2008 Aug; 19(4):355-61. PubMed ID: 18607182
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
